Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

CNV Detection

November 9, 2010 12:14 pm | Product Releases | Comments

NanoString Technologies, Inc. launched a novel solution for detecting genetic copy number variations (CNVs) associated with disease susceptibility, drug response, and cancer progression.


Winner of HCA Award Achieved 20-Fold Increase in Throughput

November 9, 2010 12:06 pm | News | Comments

GE Healthcare announced that Dr. Michael Freeley from the Institute of Molecular Medicine, Trinity College Dublin is winner of the first GE Healthcare HCA Award.


Genentech Named 2010 Facility of the Year Awards Winner

November 9, 2010 12:03 pm | News | Comments

ISPE announced that Genentech’s ECP-1 Bacterial Manufacturing Facility is the overall winner of the 2010 Facility of the Year Awards (FOYA) program.


Abbott HIV Test Kits to Clinton Health Access Initiative

November 9, 2010 5:29 am | News | Comments

Abbott and the Clinton Health Access Initiative (CHAI) have joined forces to provide HIV testing to infants in all countries working in partnership with the CHAI.


TB Alliance Launches First Clinical Trial

November 9, 2010 5:26 am | News | Comments

The Global Alliance for TB Drug Development (TB Alliance) announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients.


Report: Innovative Drug Strategies Fail to Appear

November 9, 2010 5:22 am | News | Comments

According to a new report released today by Citeline Drug Intelligence, the 240th meeting of the American Chemical Society disappointed expectations with a lack of new drug targets being announced at the event.


Fake Antimalarial Drugs Found in Ghana

November 9, 2010 5:18 am | News | Comments

Substandard and counterfeit versions of thirteen key antimalarial medicines were uncovered in multiple locations across Ghana by the Medicines Quality Monitoring surveillance program.


MDs Slash Some Drug Co. Ties Amid Rising Scrutiny

November 9, 2010 5:15 am | by Lindsey Tanner, AP Medical Writer | News | Comments

Doctors have sharply cut some financial ties to drug companies, thanks to increased scrutiny about relationships that critics say improperly influence medical treatment, a survey suggests.


Potential Drug Therapy for Diabetic Retinopathy Under Study

November 9, 2010 5:13 am | by Toni Baker | News | Comments

Resarchers studying a drug known for its pain-relieving ability appears to improve the health of retinas damaged by diabetes.


Tracking Nanoparticles From the Lungs Into the Body

November 9, 2010 5:08 am | News | Comments

Using a novel, real-time imaging system, scientists have tracked a group of near-infrared fluorescent nanoparticles from the airspaces of the lungs, into the body and out again.


BiTE Antibody Moves to Preclinical Development

November 9, 2010 5:04 am | News | Comments

Micromet, Inc. announced plans to advance the Company’s BiTE antibody MT112/BAY 2010112 into formal preclinical development in collaboration with Bayer Schering Pharma AG, Germany.


Amgen Releases Denosumab Study Results

November 9, 2010 5:01 am | News | Comments

Amgen announced the publication of results from a pivotal Phase 3 study of 2,046 patients which compared denosumab with Zometa (zoledronic acid) in delaying or preventing skeletal-related events (SREs) in breast cancer patients with bone metastases.


Multiplex Assays for Neurological Disorders

November 9, 2010 4:56 am | Product Releases | Comments

EMD Millipore announced the introduction of new multiplex assay kits that can provide greater insight into the biochemical changes associated with Alzheimer's disease, Parkinson's disease, and other neurological disorders.


Flash Cartridges

November 9, 2010 4:53 am | Product Releases | Comments

Grace Davison Discovery Sciences announced the launch of new flash cartridges in Amino and Diol phases for use with the Reveleris Flash Chromatography System.


Cancer GWAS and Data Analysis Grant Program

November 9, 2010 4:43 am | News | Comments

Expression Analysis and Illumina, Inc. are jointly funding a Cancer GWAS (Genome-Wide Association Study) and Data Analysis Grant program to support cutting-edge projects that show promise in identifying genetic elements important to cancer research and treatment.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.